Redmile Group, LLC Rapt Therapeutics, Inc. Transaction History
Redmile Group, LLC
- $2.54 Billion
- Q1 2024
A detailed history of Redmile Group, LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 662,398 shares of RAPT stock, worth $2.66 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
662,398
Previous 366,776
80.6%
Holding current value
$2.66 Million
Previous $9.11 Million
34.74%
% of portfolio
0.23%
Previous 0.36%
Shares
7 transactions
Others Institutions Holding RAPT
# of Institutions
148Shares Held
29.2MCall Options Held
709KPut Options Held
1.06M-
Column Group LLC San Francisco, CA2.68MShares$10.7 Million15.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$10 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$9.91 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.03MShares$8.13 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.91MShares$7.64 Million0.0% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $119M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...